Literature DB >> 17016783

[Needle revision of late failing filtering blebs after glaucoma surgery].

S Perucho-Martínez1, E Gutiérrez-Díaz, M Montero-Rodríguez, E Mencía-Gutiérrez, M D Lago-Llinás.   

Abstract

PURPOSE: To evaluate the results of bleb needling in eyes subjected to filtering surgery six months or more previously.
METHODS: A retrospective study of 23 eyes in 21 patients subjected to bleb needling performed by means of a 25G needle, 6 months to 23 years after failed filtering surgery (mean 67.3 months). The mean number of bleb needlings was 1.2 and the mean number of 5-fluorouracil subconjunctival injections was 3.9.
RESULTS: The mean intraocular pressure (IOP) before needling was 26 mmHg and the mean anti-glaucoma medications was 1.3 per eye. The mean postoperative IOP was 16.3 mmHg and mean anti-glaucoma medications 0.7. A diffuse filtering bleb was evident in 12 eyes (54.5%). The results of needling were worse in eyes subjected to previous surgery for glaucoma or other failed bleb needling procedures (75% failure).
CONCLUSION: Needle revision of the filtering bleb is a simple and safe technique that offers good results even years after a filtering surgery had been performed. It should be considered before other medical or surgical treatments in patients with a previously functioning bleb and a permeable sclerectomy site at gonioscopy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016783     DOI: 10.4321/s0365-66912006000900006

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  3 in total

1.  Efficacy of repeated 5-fluorouracil needling for failing and failed filtering surgeries based on simple gonioscopic examination.

Authors:  Mohammad A Rashad
Journal:  Clin Ophthalmol       Date:  2012-12-28

2.  Mitomycin-C needle bleb revision in congenital glaucoma.

Authors:  Thanaa Helmy Mohamed Elsayed; Tamer Mohamed El-Raggal
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10

3.  Early transconjunctival needling revision with 5-fluorouracil versus medical treatment in encapsulated blebs: a 12-month prospective study.

Authors:  Ricardo Suzuki; Remo Susanna
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.